Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?
Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Izdatelstvo OKI
2020-10-01
|
| Serija: | Качественная клиническая практика |
| Teme: | |
| Online dostop: | https://www.clinvest.ru/jour/article/view/522 |
| Oznake: |
Brez oznak, prvi označite!
|